MOTS-C 10MG

MOTS-C is a small mitochondrial-derived peptide derived from the mitochondrial genome of fish. Originally identified in muscle tissue of cold-adapted fish, this peptide is being extensively studied for its potential implications in metabolic regulation, mitochondrial function, and tissue homeostasis within a research context.

Research Context

MOTS-C has garnered attention in academic and preclinical research due to its structural similarities to other bioactive peptides, such as irisin, which is linked to exercise-induced adaptations. Early studies suggest that MOTS-C may promote mitochondrial biogenesis and improve energy metabolism. Research has focused on its potential role in conditions associated with mitochondrial dysfunction, such as obesity, diabetes, and aging-related syndromes.

Research Overview

Preclinical investigations have explored MOTS-C’s effects on various tissues, including skeletal muscle, adipose tissue, and the brain. While results are still emerging, initial findings highlight its potential to modulate key cellular pathways, including those involved in insulin signaling and oxidative stress response. However, further comprehensive research is required to fully elucidate its mechanisms and applications within a research framework.

Key Research Focus Areas

• Mitochondrial Biogenesis and Function
• Metabolic Regulation and Energy Homeostasis
• Adaptive Responses to Stress and Aging
• Potential in Preclinical Models of Obesity and Diabetes
• Exploration of Neuroprotective and Cognitive Effects (in animal models)

Important Compliance Notice

This product is intended solely for use in accredited research laboratories and does not possess any therapeutic, diagnostic, or cosmetic claims. Users must adhere to all applicable ethical guidelines and regulations governing research materials. Distribution or use outside of a permitted academic or research context is strictly prohibited.

For research use only. Not for human or animal consumption.